Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system

https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.132

Abstract

During the past decades, the prevalence of cancer diseases of female reproductive system has been constantly growing. The issue is especially acute in reproductive-age women because of earlier oncological pathology onset. Morpho-functional disorders and aggressive methods of anti-tumor therapy significantly affect the patients’ quality of life, psychological well-being, emotional stability, and family relationship, which leads to a limitation of physiological and social possibilities. Rehabilitation programs for oncological patients target to prevent unwanted sequela of the disease, its therapy, and relapses. Pre-rehabilitation plays a special role. It includes psychological and specialized medical care for the patient during the period from the disease verification to the start of therapy. Timely rehabilitation measures reduce the rate of repeated hospitalizations for side effects of chemotherapy, radiotherapy complications, antitumor therapy, and radical surgical interventions. Rehabilitation as a part of standard therapeutic strategy can reduce pharmacoeconomical burden for the health care system. However, further clinical and pharmacoeconomic studies are required for the implementation of rehabilitation at the level of the health care system. 

About the Authors

D. V. Blinov
Institute for Preventive and Social Medicine; Moscow Haass Medical Social Institute
Russian Federation

MD, PhD, MBA, Head of Medical and Scientific Affairs, 4/10 Sadovaya-Triumfalnaya Str., Moscow 127006;

Faculty Member, Chair of Neurology, Psychiatry and Narcology, 5 bldg 1-1a 2nd Brestskaya Str., Moscow 123056



A. G. Solopova
Sechenov University
Russian Federation

Dr. Med. Sc., Professor, Chair of Obstetrics and Gynecology, Filatov Clinical Institute of Children's Health,

8/2 Trubetskaya Str., Moscow 119991



A. N. Plutnitskiy
Ministry of Health of the Russian Federation; Medico-Biological University of Innovation and Continuing Education, State Scientific Center of the Russian Federation – Burnazyan Federal Medical Biophysical Center, Federal Medical and Biological Agency of Russia
Russian Federation

 Dr. Med. Sc., Professor, Deputy Minister of Health of the Russian Federation, Director of the Department of Project Activities, 3 Rakhmanovskiy Aly, Moscow 127994;

Chief of Chair of Public Health and Healthcare with a Course of Medical and Social Expertise, 46 bldg 8 Zhivopisnaya Str., Moscow 123098



D. M. Ampilogova
Sechenov University
Russian Federation

 Clinical Resident, Chair of Obstetrics and Gynecology, Sklifosovsky Institute of Clinical Medicine, 

8/2 Trubetskaya Str., Moscow 119991



L. N. Sandzhieva
Sechenov University
Russian Federation

Postgraduate, Chair of Obstetrics and Gynecology, Filatov Clinical Institute of Children's Health,

8/2 Trubetskaya Str., Moscow 119991



D. I. Korabel’nikov
Moscow Haass Medical Social Institute
Russian Federation

MD, PhD, Professor, Chair of Internal Diseses with Courses of Family Medicine, Functional Diagnostics, Infectious Diseases, Rector, 

5 bldg 1-1a 2nd Brestskaya Str., Moscow 123056



D. A. Petrenko
Sechenov University
Russian Federation

6th Year Student, 

8/2 Trubetskaya Str., Moscow 119991



References

1. Sung H., Ferlay J., Siegel R.L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71 (3): 209–49. https://doi.org/10.3322/caac.21660.

2. Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021; 18 (10): 663–72. https://doi.org/10.1038/s41571-021-00514-z.

3. Vlasina A.V., Idrisova L.E., Solopova A.G., et al. Rehabilitation of oncogynecological patients after antitumor therapy: ways of solution. Obstetrics, Gynecology and Reproduction. 2020; 14 (1): 44–55 (in Russ.). https://doi.org/10.17749/2313-7347.2020.14.1.44-55.

4. Kaprin A.D., Starinskiy V.V., Petrova G.V. (Eds.) Malignant neoplasms in Russia in 2018 (morbidity and mortality). Мoscow; 2019: 250 pp. Available at: https://oncology-association.ru/wpcontent/uploads/2020/09/2018.pdf (in Russ.) (accessed 03.02.2022).

5. Solopova A.G., Idrisova L.E., Makatsariya A.D., et al. Multidisciplinary approach to medical rehabilitation of oncogynecologic patients. Obstetrics, Gynecology and Reproduction. 2017; 11 (4): 57–67 (in Russ.). https://doi.org/10.17749/2313-7347.2017.11.4.057-067.

6. Stucki G., Bickenbach J., Gutenbrunner C., Melvin J. Rehabilitation: the health strategy of the 21st century. J Rehabil Med. 2018; 50 (4): 309–16. https://doi.org/10.2340/16501977-2200.

7. Solopova A.G., Tabakman Y.Y., Idrisova L.E., Sdvizhkov A.M. Rehabilitation of oncogynecologic patients. View of a problem. Obstetrics, Gynecology and Reproduction. 2015; 9 (4): 46–54 (in Russ.). https://doi.org/10.17749/2070-4968.2015.9.4.046-054.

8. Rehabilitation 2030: a call for action. February 6–7, 2017. Executive Boardroom, WHO Headquarters. Meeting Report. Available at: https://www.who.int/disabilities/care/Rehab2030MeetingReport_plain_text_ version.pdf (in Russ.) (accessed 03.02.2022).

9. Hoenig H., Nusbaum N., Brummel-Smith K. Geriatric rehabilitation: state of the art. J Am Geriatri Soc. 1997; 45 (11): 1371–81. https://doi.org/10.1111/j.1532-5415.1997.tb02939.x.

10. Saotome T., Klein L., Faux S. Cancer rehabilitation: a barometer for survival? Support Care Cancer. 2015; 23 (10): 3033–41. https://doi.org/10.1007/s00520-015-2673-1.

11. Anwar S.L., Adistyawan G., Wulaningsih W., et al. Rehabilitation for cancer survivors: how we can reduce the healthcare service inequality in low- and middle-income countries. Am J Phys Med Rehabil. 2018; 97 (10): 764–71. https://doi.org/10.1097/PHM.0000000000000982.

12. Miralpeix E., Mancebo G., Gayete S., et al. Role and impact of multimodal prehabilitation for gynecologic oncology patients in an Enhanced Recovery After Surgery (ERAS) program. Int J Gynecol Cancer. 2019; 29 (8): 1235–43. https://doi.org/10.1136/ijgc-2019-000597.

13. Vonk Noordegraaf A., Anema J.R., van Mechelen W., et al. A personalised eHealth programme reduces the duration until return to work after gynaecological surgery: results of a multicentre randomised trial. BJOG. 2014; 121 (9): 1127–35. https://doi.org/10.1111/1471-0528.12661.

14. Hawkes A.L., Quinn M., Gebski V., et al. Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial. Contemp Clin Trials. 2014; 39 (1): 14–21. https://doi.org/10.1016/j.cct.2014.06.014.

15. Falcicchio C., Di Lallo D., Fabi A., et al. Use of rehabilitation pathways in women with breast cancer in the first 12 months of the disease: a retrospective study. BMC Cancer. 2021; 21 (1): 311. https://doi.org/10.1186/s12885-021-07927-0.

16. Sun Y., Shigaki C.L., Armer J.M. Return to work among breast cancer survivors: a literature review. Support Care Cancer. 2017; 25 (3): 709–18. https://doi.org/10.1007/s00520-016-3446-1.

17. Dholakia J., Cohn D.E., Straughn J.M., Dilley S.E. Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis. J Gynecol Oncol. 2021; 32 (6): e92. https://doi.org/10.3802/jgo.2021.32.e92.

18. May A.M., Bosch M.J., Velthuis M.J., et al. Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study. BMJ Open. 2017; 7 (3): e012187. https://doi.org/10.1136/bmjopen-2016-012187.

19. Gordon L.G., Eakin E.G., Spence R.R., et al. Cost-effectiveness analysis from a randomized controlled trial of tailored exercise prescription for women with breast cancer with 8-year follow-up. Int J Environ Res Public Health. 2020; 17 (22): 8608. https://doi.org/10.3390/ijerph17228608.

20. Thorsen L., Gjerset G.M., Loge J.H., et al. Cancer patients' needs for rehabilitation services. Acta Oncol. 2011; 50 (2): 212–22. https://doi.org/10.3109/0284186X.2010.531050.

21. Butow P.N., Price M.A., Bell M.L., et al. Caring for women with ovarian cancer in the last year of life: a longitudinal study of caregiver quality of life, distress and unmet needs. Gynecol Oncol. 2014; 132 (3): 690–7. https://doi.org/10.1016/j.ygyno.2014.01.002.

22. Holm L.V., Hansen D.G., Kragstrup J., et al. Influence of comorbidity on cancer patients' rehabilitation needs, participation in rehabilitation activities and unmet needs: a population-based cohort study. Support Care Cancer. 2014; 22 (8): 2095–105. https://doi.org/10.1007/s00520-014-2188-1.

23. Seland M., Skrede K., Lindemann K., et al. Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstet Gynecol Scand. 2022; 101 (3): 313–22. https://doi.org/10.1111/aogs.14310.

24. Blinov D.V., Akarachkova E.S., Ampilogova D.M., et al. Depression in postmenopause: interdisciplinary approach in management and perspectives for rehabilitation. Obstetrics, Gynecology and Reproduction. 2021; 15 (6): 738–54 (in Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.280.

25. Almont T., Bujan L., Joachim C., et al. Collaborative digital platform France – Cuba: oncorehabilitation in reproductive and sexual health. BMC Med Educ. 2021; 21 (1): 337. https://doi.org/10.1186/s12909-021-02774-w.


Review

For citations:


Blinov D.V., Solopova A.G., Plutnitskiy A.N., Ampilogova D.M., Sandzhieva L.N., Korabel’nikov D.I., Petrenko D.A. Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022;15(1):119-130. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.132

Views: 282


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)